Latest article
Provention Bio Supplies Regulatory Replace on Biologics License Software for Teplizumab for the Delay...
RED BANK, NJ, April 8, 2021 / PRNewswire / - Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to catching and preventing immune-related...
ViaCyte Declares Initiation of Part 2 Research of Encapsulated Cell Remedy for Kind 1...
SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with type...
